On the 31st May in London, the Judges Scientific AGM was attended by only three shareholders, one of whom was a company employee (he was a former director of one of the companies they took over – at least he appeared to be happy working for them as he had even bought more shares after receiving some from the takeover). The formal business was fairly routine, although it transpired that the resolution to permit allotment of shares (no. 7) actually enables the company to issue as many again as already in issue without reverting to the shareholders for approval. This is unusual and is contrary to ABI guidelines. The risk is that if a large bid target appears, or the company gets into difficulties, the directors could arrange a large
...Not a member? Join today
Joining ShareSoc helps to empower our collective voice in representing investors, but we also offer exclusive benefits:
Member events & Masterclasses
Regular newsletter
Member only on-line Forums / Q&As
Company data and Voting Guidance
Educational resources
Get involved in our activities
Already a member?
Log in to your account to access this content and all of your other ShareSoc membership benefits.